Press release content from NewMediaWire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from NewMediaWire
Press release content from NewMediaWire. The AP news staff was not involved in its creation.

SmallCapsDaily: QIPT Emerges As a Leader Within the New Generation of Medical Device Suppliers

July 12, 2021 GMT

New York, NY - ( NewMediaWire ) - July 12, 2021 - Quipt Home Medical Corp. (“Quipt” or the “Company”) (NASDAQ:QIPT; TSXV:QIPT), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, was recently the focus of an article by leading financial news website and publisher, SmallCapsDaily. The article describes Quipt Home Medical’s emergence as a leader within the home medical device industry. As a result of the pandemic, home medical device requirements surged and Quipt Home Medical met the demand with its innovative subscription services and its novel platform technology, including the Durable Medical Equipment (DME) delivery process. Quipt Home Medical, is headquartered in Kentucky and in addition to supplying in-home monitoring equipment, provides daily and ambulatory aides, oxygen therapy, sleep apnea treatment, home ventilation, and respiratory equipment rentals across North America.


For  more  detailed information visit: https://smallcapsdaily.com/quipt-home-medical-a-new-generation-medical-equipment-supplier/

Key Takeaways

  • Quipt Home Medical delivers nearly 250,000 pieces of equipment every year to a network of more than 17,000 referring physicians across the world. It operates on a subscription-based revenue model that provides initial equipment supply and implementation to thousands of patients every year.
  • Quipt’s significant technological investment in its unique platform has allowed the company to offer exceptional services to its patients. This is a major differentiating factor between Quipt and its competitors. Quipt has also simplified the Durable Medical Equipment (DME) delivery process which in turn helped Quipt partner with a number of physicians over the last few years.
  • Quipt’s Sleepwell re-supply program is expected to significantly reduce fulfilment errors and increase overall volumes. The company is currently obtaining $25 million from its re-supply subscription model and is expecting that it will increase to over $30 million with the Sleepwell program fully integrated.



The Company provides in-home monitoring and disease management services including end-to-end respiratory solutions for patients in the United States healthcare market. It seeks to continue to expand its offerings to include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility and other chronic health conditions. The primary business objective of the Company is to create shareholder value by offering a broader range of services to patients in need of in-home monitoring and chronic disease management. The Company’s organic growth strategy is to increase annual revenue per patient by offering multiple services to the same patient, consolidating the patient’s services, and making life easier for the patient.

There can be no assurance that any of the potential acquisitions in advanced negotiations will be completed as proposed or at all and no definitive agreements have been executed. Completion of any transaction will be subject to applicable directors, shareholder and regulatory approvals.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of ‎the ‎TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.‎

Forward-looking Statements
SmallCapsDaily profiles are not a solicitation or recommendation to buy, sell or hold securities. SmallCapsDaily is a paid advertiser and is not offering securities for sale. Neither SmallCapsDaily nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by SmallCapsDaily its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. Small Caps Daily does not recommend that the securities profiled should be purchased, sold or held and is not liable for any investment decisions by its readers or subscribers. Information presented by Small Caps Daily may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance, are not statements of historical fact and may be “forward-looking statements.” Forward-looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward-looking statements may be identified through the use of words such as “expects,” “will,” “anticipates,” “estimates,” “believes,” “may,” or by statements indicating that certain actions “may,” “could,” or “might” occur.